Whitehawk Therapeutics (WHWK) Gains from Sales and Divestitures (2016 - 2026)
Whitehawk Therapeutics (WHWK) reported Gains from Sales and Divestitures of $51000.0 for Q1 2026, down 19.05% year-over-year from $63000.0 in Q1 2025, and down 86.86% on a QoQ basis from $388000.0 in Q4 2025.
Whitehawk Therapeutics (WHWK) has 5 years of Gains from Sales and Divestitures data on file, last reported at $51000.0 in Q1 2026.
- Quarterly Gains from Sales and Divestitures fell 19.05% year-over-year to $51000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $51000.0 (down 19.05% YoY) and the FY2025 annual result came in at $388000.0, changed N/A from the prior year.
- Gains from Sales and Divestitures retreated to $51000.0 in Q1 2026 per WHWK's latest filing, from $388000.0 in the prior quarter.
- Across five years, Gains from Sales and Divestitures topped out at $388000.0 in Q4 2025 and bottomed at $51000.0 in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51,000.00 |
| Mar 31, 2026 | 51,000.00 |
| Dec 31, 2025 | 388,000.00 |
| Dec 31, 2025 | 388,000.00 |
| Sep 30, 2025 | 387,925.00 |
| Sep 30, 2025 | 387,925.00 |
| Jun 30, 2025 | 325,000.00 |
| Jun 30, 2025 | 325,000.00 |
| Mar 31, 2025 | 63,000.00 |
| Mar 31, 2025 | 63,000.00 |
| Dec 31, 2018 | 149,243.00 |
| Dec 31, 2018 | 149,243.00 |
| Sep 30, 2018 | 142,205.00 |
| Sep 30, 2018 | 142,205.00 |
| Jun 30, 2018 | 97,020.00 |
| Jun 30, 2018 | 97,020.00 |
| Mar 31, 2018 | 70,605.00 |
| Mar 31, 2018 | 70,605.00 |
| Dec 31, 2017 | 144,274.00 |
| Dec 31, 2017 | 144,274.00 |
| Sep 30, 2017 | 106,015.00 |
| Sep 30, 2017 | 106,015.00 |
| Jun 30, 2017 | 67,126.00 |
| Jun 30, 2017 | 67,126.00 |
| Mar 31, 2017 | 39,455.00 |
| Mar 31, 2017 | 39,455.00 |
| Dec 31, 2016 | 203,103.00 |
| Dec 31, 2016 | 203,103.00 |